Tag: Synnovation Therapeutics

Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways

Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways

– Series A Financing led by Third Rock Ventures and includes Nextech, Lilly Asia Ventures, Sirona Capital and Cormorant Asset Management – January 24, 2024 07:00 AM Eastern Standard Time WILMINGTON, Del.–(BUSINESS WIRE)–Synnovation Therapeutics, a…

Read More Read More

Synnovation Therapeutics has filed a notice of an exempt offering of securities to raise $24,999,998.00 in New Equity Investment.

Synnovation Therapeutics has filed a notice of an exempt offering of securities to raise $24,999,998.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Synnovation Therapeutics is raising $24,999,998.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Wenqing Yao played a key role…

Read More Read More

Wilmington Delaware based Synnovation Therapeutics is raising $19,999,625.00 in New Equity Investment.

Wilmington Delaware based Synnovation Therapeutics is raising $19,999,625.00 in New Equity Investment.

Wilmington, DE – According to filings with the U.S. Securities and Exchange Commission, Synnovation Therapeutics is raising $19,999,625.00 in new funding. Sources indicate as part of senior management President, Wenqing Yao played a key role…

Read More Read More